ArticlePLOS digital health2026
Reliable detection and continuous monitoring of memory dysfunction in mild cognitive impairment and healthy aging through adaptive computational phenotyping.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
With the rising prevalence of age-related memory impairments, efficiently detecting and monitoring decline is increasingly urgent. Unfortunately, traditional assessment methods fall short of these needs, as they typically require in-person administration and cannot be repeated frequently. Here, we demonstrate that remote identification and monitoring of abnormal memory function is possible by combining an online assessment platform with computational phenotyping, allowing repeatable, unsupervised remote observations from patients. Fifty-one well-characterized older individuals, including 24 patients with amnestic mild cognitive impairment and 27 age- and education-matched healthy controls, completed a series of longitudinal, unsupervised, remote weekly 8-minute online memory assessments for up to one year. Weekly test data were fit to a formal model of memory consolidation and forgetting, yielding an individualized index of memory function, the Seattle-Groningen Memory Assessment (SGMA) score. The SGMA score was found to be reliable, with a mean correlation of r = 0.70 across assessments. The score was also found to be stable across different study materials, and only barely affected by practice effects, which averaged to a 0.2% increase per assessment. Finally, the SGMA score was found to be diagnostic, being capable of detecting mild cognitive impairment with up to 87% accuracy. These findings show that model-based, adaptive assessments can support high-frequency, remote detection and scalable longitudinal monitoring of early memory decline, providing a new way to assess memory decline trajectories in healthy aging and dementia.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.